logo
CRYOPRESERVATION OF HUMAN ISLETS OF LANGERHANS
SPONTANEOUS ACCEPTANCE OR REJECTION OF ORTHOTOPIC LIVER TRANSPLANTS IN OUTBRED AND PARTIALLY INBRED MINIATURE SWINE
PHASE I TRIAL OF A HUMANIZED, Fc RECEPTOR NONBINDING OKT3 ANTIBODY, huOKT3γ1 (Ala-Ala) IN THE TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION
CD3 ANTIBODY-INDUCED IL-10 IN RENAL ALLOGRAFT RECIPIENTS
THE IMPACT OF RECURRENT GLOMERULONEPHRITIS ON GRAFT SURVIVAL IN RECIPIENTS OF HUMAN HISTOCOMPATIBILITY LEUCOCYTE ANTIGEN-IDENTICAL LIVING RELATED DONOR GRAFTS
COMPARISONS OF ALLOREACTIVE POTENTIAL OF CLINICAL HEMATOPOIETIC GRAFTS1
RECURRENT AND DE NOVO GLOMERULAR DISEASE AFTER RENAL TRANSPLANTATION
A BLINDED RETROSPECTIVE ANALYSIS OF RENAL ALLOGRAFT PATHOLOGY USING THE BANFF SCHEMA
SPECIFIC VASCULAR COMPLICATIONS OF ORTHOTOPIC LIVER TRANSPLANTATION WITH PRESERVATION OF THE RETROHEPATIC VENA CAVA: REVIEW OF 1361 CASES
AN ANALYSIS OF PRETRANSPLANTATION VARIABLES ASSOCIATED WITH LONG-TERM ALLOGRAFT OUTCOME IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS RECEIVING PRIMARY TACROLIMUS (FK506) THERAPY
EFFECTS OF CRYOPRESERVATION ON IN VITRO AND IN VIVO LONG-TERM FUNCTION OF HUMAN ISLETS1
SAFETY, TOLERABILITY AND EFFICACY OF CYCLOSPORINE MICROEMULSION IN HEART TRANSPLANT RECIPIENTS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND COMPARISON WITH THE OIL BASED FORMULATION OF CYCLOSPORINE - RESULTS AT SIX MONTHS AFTER TRANSPLANTATION1,2
PRESERVED VASCULAR HOMOGRAFT FOR REVASCULARIZATION OF PEDIATRIC LIVER TRANSPLANT1
DOWN-REGULATION OF INTERLEUKIN-2 AND INTERFERON-γ AND MAINTENANCE OF INTERLEUKIN-4 AND INTERLEUKIN-10 PRODUCTION AFTER ADMINISTRATION OF AN ANTI-CD3 MONOCLONAL ANTIBODY IN MICE1
PEPTIDES DERIVED FROM ICAM-1 AND LFA-1 MODULATE T CELL ADHESION AND IMMUNE FUNCTION IN A MIXED LYMPHOCYTE CULTURE1
ACTIVATION OF T LYMPHOCYTES FOR ADHESION AND CYTOKINE EXPRESSION BY TOXIN-CONJUGATED ANTI-CD3 MONOCLONAL ANTIBODIES1
INTESTINAL MICROSPORIDIOSIS OCCURRING IN TWO RENAL TRANSPLANT RECIPIENTS TREATED WITH MYCOPHENOLATE MOFETIL
USE OF ANTI-CD25 MONOCLONAL ANTIBODY IN COMBINATION WITH RAPAMYCIN TO ELIMINATE CYCLOSPORINE TREATMENT DURING THE INDUCTION PHASE OF IMMUNOSUPPRESSION1
IMPROVED HUMAN ISLET ISOLATION BY A TUBE METHOD FOR COLLAGENASE INFUSION1
A COMMENTARY ON A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS
ADMINISTRATION OF OKT3 AS A TWO-HOUR INFUSION DOES NOT ATTENUATE FIRST-DOSE SIDE EFFECTS
VIRUSES AND THROMBOTIC MICROANGIOPATHY
ERRATA
ANNOUNCEMENTS